Text Size

Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients

This study has been completed.
Sponsor:
Information provided by:
University of Utah
ClinicalTrials.gov Identifier:
NCT00810784
First received: December 16, 2008
Last updated: December 17, 2008
Last verified: December 2008
History of Changes
  Purpose

VTE prophylaxis is not as routinely employed in medically ill patients as compared to surgical patients. This retrospective chart review project will evaluate the effectiveness of VTE prophylaxis in medically ill patients at the University of Utah Hospitals and Clinics compared to current literature. The study will ultimately serve as a quality improvement project to help improve patient care.


Condition Intervention
Venous Thromboembolism
 Behavioral: Education

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Utah:

Enrollment: 121
Study Start Date: March 2005
Study Completion Date: March 2007
Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Patients cared for before our intervention.
2
Patients cared for after our intervention.
 Behavioral: Education
(1) a risk-assessment tool completed at the time of a hospital admission, (2) structured educational sessions on VTE prevention, and (3) audit-feedback where institutional data was reviewed during the educational sessions. These sessions were given once to the clinical pharmacists and on three separate occasions to the medicine house officers.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Data was collected on consecutive patients ≥18 years with a hospital length of stay of >48 hours admitted to the cardiology, pulmonary, or general medical services. Admission dates were a sample of two different two-week blocks (January 1-14, 2006 and April 1-14, 2006). These blocks were chosen to be consistent with dates of analysis in the pre-intervention cohort. Patients receiving therapeutic anticoagulation were excluded.

Criteria

Inclusion Criteria:

  • Hospitalized at the University of Utah on one our medical services.

Exclusion Criteria:

  • Patients received therapeutic anticoagulation.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00810784

Locations
United States, Utah
University of Utah Health Sciences Center
Salt Lake City, Utah, United States, 84132
Sponsors and Collaborators
University of Utah
Investigators
Principal Investigator: Matthew Rondina, M.D. University of Utah
  More Information

Publications:

Responsible Party: Robert Pendleton, M.D., Associate Professor, University of Utah, University of Utah
ClinicalTrials.gov Identifier: NCT00810784     History of Changes
Other Study ID Numbers: UUHSC-IRB-00018164
Study First Received: December 16, 2008
Last Updated: December 17, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by University of Utah:
Venous Thromboembolism
Prevention
Quality Improvement
Education
Compliance with VTE prophylaxis

Additional relevant MeSH terms:
Thromboembolism
Venous Thromboembolism
Venous Thrombosis
Embolism and Thrombosis
 Vascular Diseases
Cardiovascular Diseases
Thrombosis

ClinicalTrials.gov processed this record on May 16, 2013